The dollar index, which measures the U.S. currency against six rivals, was at 98.193, hovering near the lowest level since October 3 which it hit on Tuesday. The index is down 9.5% this year, on pace ...

TOKYO, Dec 17 (Reuters) - U.S. crude futures rose more than 1% on Wednesday as U.S. President Donald Trump ordered "a total and complete" blockade of all sanctioned oil tankers entering and leaving ...

The S&P 500 and the Dow Jones Industrial Average ended lower on Tuesday amid heightened caution over the U.S. economy, which ...

Investing.com-- Tesla Inc’s (NASDAQ:TSLA) sales in California are set to be suspended for 30 days as a penalty for allegedly misleading customers over the electric vehicle maker’s driver-assistance ...

SAN FRANCISCO, Dec 16 (Reuters) - A California regulator allowed Tesla to continue selling vehicles in the state for now, the latest move in a case in which the electric vehicle maker had been accused ...

U.S. crude futures climbed over 1% to $55.96 a barrel in Asian trading after Trump ordered a blockade on sanctioned oil ...

Trade balance was a surplus of 322.2 billion yen ($2.08 billion) in November, government data showed on Wednesday. The print ...

The PERSEUS trial was a global, double-blind, randomized Phase 3 study comparing tolebrutinib to placebo in PPMS patients.

Spot silver rose 2.3% to a record high of $65.3415 an ounce, while silver futures jumped 3.6% to $65.640/oz. Other precious metals– specifically gold and platinum – also advanced on Wednesday. But ...

Bloomberg News also reported that Waymo is looking to raise more than $15 billion at a valuation near $100 billion, in a round led by parent Alphabet. Alphabet and Waymo did not immediately respond to ...

Investing.com -- Waymo, the autonomous driving unit of Alphabet (NASDAQ:GOOGL), is in discussions to raise more than $15 billion at a valuation approaching $100 billion, according to reporting from ...

Investing.com -- DBV Technologies (NASDAQ:DBVT) stock soared 65.2% in after-hours trading Tuesday following the announcement of positive topline results from its Phase 3 VITESSE trial for the VIASKIN ...